Ladenburg, Germany, 24 April 2025 - Heidelberg Pharma AG (FSE: HPHA) today reported on the first three months of fiscal year 2025 (1 December 2024 – 28 February 2025) and the Group’s financial figures ...

Marly Garnreiter plugged her mysterious symptoms into ChatGPT but "ignored" the results — until doctors came to the same ...

A mother-of-three is urging women to consider the health implications of cosmetic surgery, following an alarming discovery ...

Diffuse large B-cell lymphoma (DLBCL) is the most common and fast-growing type of non-Hodgkin lymphoma, a cancer that affects ...

It’s spring, a time for new beginnings following a cancer diagnosis; however, I have an ongoing issue that I can’t dismiss.

Dave Coulier revealed on the 'How Rude, Tanneritos!' podcast that he celebrated two huge milestones on the same day.

Progress has been made in reducing overall cancer mortality, largely driven by sustained declines in lung cancer,” the researchers wrote.

Coulier shared the exciting news on Saturday’s episode of the “How Rude, Tanneritos!” podcast with two of his former “Full ...

This study presents a valuable finding on the direct cytotoxic effects of DuoHexaBody-CD37 in diffuse large B-cell lymphoma, mediated via SHP-1 activation and antibody clustering, independent of ...

Monsanto, which on April 9 petitioned the U.S. Supreme Court to review its federal preemption defense in a Missouri case, ...

Overall, rates of new cancer diagnoses and cancer-related deaths have declined, according to the annual cancer statistics ...

In part 4 of an interview with The American Journal of Managed Care®, Frederick L. Locke, MD, provides insight on the design ...